Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Evaluation of risk factors, primary diagnosis, causes, and outcomes of repeat endoscopic retrograde cholangiopancreatography

  • Denis Jevdokimov*
  • , Natalija Jevdokimova
  • , Aldis Pukitis
  • *Šī darba korespondējošais autors
  • Paula Stradina Clinical University Hospital
  • University of Latvia

Zinātniskās darbības rezultāts: Devums žurnālamZinātniskais raksts (žurnālā)koleģiāli recenzēts

Kopsavilkums

Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive endoscopic method that is used for the diagnosis and treatment of pancreaticobiliary diseases. ERCP may have to be performed two or more times, which carries a risk of complications and even death. Various risk factors influence the likelihood of ERCP recurrence. Methods: A retrospective study was conducted at Pauls Stradins Clinical University Hospital. Fifty patients with a history of repeat ERCP were enrolled. The total ERCP count was 122. The total death rate, 30-day postprocedural mortality, laboratory markers, and primary diagnosis were analyzed, and the therapeutic interventions used during ERCP, common bile duct’s diameter, and causes of repeat ERCP were evaluated. Results: The postprocedural 30-day mortality of repeat ERCP was 3.3%, and the overall death rate was 8%. We found a significant difference between the number of repeat ERCPs and exitus letalis (mean = 2.25 vs. mean = 1.37). The most common primary diagnosis for repeat ERCP was choledocholithiasis (64%; n = 32). We found a significant relationship between choledocholithiasis and history of cholecystectomy (P < 0.001) and obesity (P < 0.001). The rate of successful cannulation for ERCP reached 88.5%, with a significant difference between the success of cannulation and bilirubin level (205.64 ± 234.42 µmol/L vs. 58.71 ± 97.65 µmol/L, P = 0.037). The results showed a significant relationship between the success of cannulation and the presence of jaundice (P = 0.014) and periampullary diverticulum (P = 0.017). Conclusion: A greater number of repeated ERCPs carries a higher risk of overall death outcome. The disturbances in laboratory markers (decreased hemoglobin; elevated leucocytes, bilirubin, creatinine, alkaline phosphatase, C-reactive protein) could be a risk factor for negative 30-day postprocedural outcome. The risk factors for repeating ERCP include adiposity, history of cholecystectomy, bilirubin level, jaundice, and periampullary diverticulum.

OriģinālvalodaAngļu
Lapas (no-līdz)86-90
Lapu skaits5
ŽurnālsInternational Journal of Gastrointestinal Intervention
Sējums13
Izdevuma numurs3
DOIs
Publikācijas statussPublicēts - jūl. 2024

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Evaluation of risk factors, primary diagnosis, causes, and outcomes of repeat endoscopic retrograde cholangiopancreatography”. Kopā tie veido unikālu nospiedumu.

Citēt šo